Your search history is turned on.
Date: April 25, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - CAL01-#955691-v1-Certificate_-_Abridgement_of_Time_Periods_under_NI_54-101.DOC BIOSYENT INC. CERTIFICATE Pursuant to Section 2.20 of National Instrument 54-101 Communication With Beneficial Owners of Securities of a Reporting Issuer (NI 54-101) I, Robert J. March, Chief Financial Officer of BioSyent Inc. (the Corporatio...
BioSyent, 2023 Annual Report 2 0 2 3 A N N U A L R E P O R T b BioSyent, 2023 Annual Report BioSyent Corporate Profile BioSyent is a Canadian specialty pharmaceutical company focused on sourcing, acquiring or in- licensing and further developing innovative pharmaceutical and other healthcare products that improve the lives of patients an...
Security Class Holder Account Number Form of Proxy - Annual General and Special Meeting to be held on May 16, 2024 This Form of Proxy is solicited by and on behalf of Management. Notes to proxy 1. Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting ...
BIOSYENT INC. MANAGEMENT INFORMATION CIRCULAR In connection with the Annual General and Special Meeting of Shareholders on May 16, 2024 April 5, 2024 Management Information Circular 1 YOUR VOTE IS IMPORTANT This management information circular contains important ...
BioSyent Inc. 2 BIOSYENT INC. NOTICE OF OUR 2024 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS When 9:00 a.m. (EDT) Thursday, May 16, 2024 Where Hilton Mississauga/Meadowvale 6750 Mississauga Road, Mississauga, ON Items of business 1. to receive the audited consolidated financial statements for the fiscal year ended Decemb...
Date: April 23, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioSyent to Attend Planet MicroCap Showcase MISSISSAUGA, Ontario, April 23, 2024 -- BioSyent Inc. (BioSyent, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th May 2nd at the Paris Hotel & Casino. Mr. Ren Goehrum, President and CEO of BioSyent, will attend a Fireside Q&A session for investors at the conference on Wedn...
Date: April 15, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioSyent Announces Extension of RepaGyn and Proktis-M Agreement MISSISSAUGA, Ontario, April 15, 2024 -- BioSyent Inc. (BioSyent, the Company, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (BioSyent Pharma), has extended its Exclusive License and Distribution Agreement with its European partner for the RepaGyn and Proktis-M products, extending BioSy...
Date: April 10, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference MISSISSAUGA, Ontario, April 10, 2024 -- BioSyent Inc. (BioSyent, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2024 Bloom Burton & Co. Healthcare Investor Conference. The conference will be held in Toronto at the Metro Toronto Convention Centre (North Building) on Tuesday, April 16 and W...
Date: April 3, 2024 Jurisdictions: Alberta, British Columbia, Ontario
FeraMAX est la marque de supplment de fer que les pharmaciens et les mdecins au Canada recommandent le plus souvent depuis neuf annes conscutives Mississauga (Ontario), 03 avr. 2024 -- BioSyent Inc. ( BioSyent , titre la Bourse de croissance TSX : RX) est fire dannoncer que FeraMAXMD est la marque de supplment de fer la plus recommande au Canada selon un sondage pancanadien auprs des pha...
FeraMAX Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year MISSISSAUGA, Ontario, April 03, 2024 -- BioSyent Inc. (BioSyent, TSX Venture: RX) is pleased to announce that FeraMAX is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and physicians(1). This year marks the ninth consecutive year tha...